featured
Predicting Cognitive Decline in Older People With Type 2 Diabetes Through Baseline Inflammatory Marker Levels
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
Diabetologia 2022 Mar 01;65(3)467-476, AJ Sluiman, S McLachlan, RB Forster, MWJ Strachan, IJ Deary, JF PriceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.